"Ryan Sperry, VP of integrated client solutions, Basis Technologies: The Trump administration and those close to it have made it clear they’re not fans of how prevalent pharma marketing is in the U.S. Some of the opinions from those like RFK Jr. even suggest getting rid of pharmaceutical advertising altogether, though that would clash with First Amendment protections. I expect the industry will see tighter regulations around how patient data is used in advertising, a trend already occurring with legislation like Washington’s My Health My Data Act, which other states are beginning to adopt."
Read more in MedAdNews.
"The AdExchanger Awards celebrate the organizations, technologies and teams driving measurable impact across today’s advertising ecosystem. On September 28, more ...
"When you walk into a grocery store to buy produce, you usually look at the label. You want to know ...
"Each year, marketers have the same question: Did the holiday shopping season start earlier? Seasonal merchandise begins to appear in ...
